YANHONG LIU to Cyclin-Dependent Kinase Inhibitor p16
This is a "connection" page, showing publications YANHONG LIU has written about Cyclin-Dependent Kinase Inhibitor p16.
Connection Strength
0.050
-
Germline rearrangements in families with strong family history of glioma and malignant melanoma, colon, and breast cancer. Neuro Oncol. 2014 Oct; 16(10):1333-40.
Score: 0.028
-
Chromosome 7p11.2 (EGFR) variation influences glioma risk. Hum Mol Genet. 2011 Jul 15; 20(14):2897-904.
Score: 0.023